GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elbit Imaging Ltd (OTCPK:EMITF) » Definitions » Total Payout Ratio

Elbit Imaging (Elbit Imaging) Total Payout Ratio : 0.00 (As of May. 15, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Elbit Imaging Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Elbit Imaging's current Total Payout Ratio is 0.00.


Elbit Imaging Total Payout Ratio Historical Data

The historical data trend for Elbit Imaging's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elbit Imaging Total Payout Ratio Chart

Elbit Imaging Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -0.14 -32.44 0.44

Elbit Imaging Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -2.25 - - -

Competitive Comparison of Elbit Imaging's Total Payout Ratio

For the Medical Devices subindustry, Elbit Imaging's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elbit Imaging's Total Payout Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Elbit Imaging's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Elbit Imaging's Total Payout Ratio falls into.



Elbit Imaging Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Elbit Imaging's Total Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 2.525 + -0.361) / -4.908
=0.44

Elbit Imaging's Total Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0 + 0) / -2.307
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elbit Imaging Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Elbit Imaging's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Elbit Imaging (Elbit Imaging) Business Description

Traded in Other Exchanges
Address
3 Shimshon Street, Olympia A Tower, Petach Tikva, ISR, 4900102
Elbit Imaging Ltd is an Israel based company. The business activity of the group is operated through two segments including Medical industries and devices, and Plots in India. Geographically the business presence is in the region of America, Europe, and ROW. The company derives maximum revenue from the Medical industries and devices segment which operates in the field of life science that includes development, production, and marketing of treatment-oriented medical systems, and for certain cancer diseases in the America region.